Mitchel L. Zoler, PhD

Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler

News

Pediatric self-administration drives cough and cold drug mishaps

Author:: Mitchel L. Zoler, PhD

Publish date: May 2, 2016

Key clinical point: Serious adverse events in U.S.

News

ACCELERATE: Evacetrapib’s clinical failure sinks lipid-drug class

Author:: Mitchel L. Zoler, PhD

Publish date: April 20, 2016

Key clinical point: Despite producing dramatically beneficially changes in lipid levels, treatment with evacetrapib failed to produce clinical ben...

News

PPI cuts GI events from low- and high-dose aspirin

Author:: Mitchel L. Zoler, PhD

Publish date: April 14, 2016

Key clinical point: In patients at high risk of cardiovascular disease on dual-antiplatelet therapy, concurrent proton pump inhibitor treatment cu...

News

PPI Cuts GI Events From Low- and High-dose Aspirin

Author:: Mitchel L. Zoler, PhD

Publish date: April 14, 2016

Key clinical point: In patients at high risk of cardiovascular disease on dual-antiplatelet therapy, concurrent proton pump inhibitor treatment cu...

News

Ticagrelor Cuts Post-MI Events in Diabetes Patients

Author:: Mitchel L. Zoler, PhD

Publish date: April 13, 2016

Key clinical point: Among post-MI patients with diabetes, dual-antiplatelet therapy with aspirin and ticagrelor produced a significant drop in the...

News

Ticagrelor cuts post-MI events in diabetes patients

Author:: Mitchel L. Zoler, PhD

Publish date: April 13, 2016

Key clinical point: Among post-MI patients with diabetes, dual-antiplatelet therapy with aspirin and ticagrelor produced a significant drop in the...

Video

VIDEO: Serial lung fluid measurement improved heart failure outcomes

Author:: Mitchel L. Zoler, PhD

Publish date: April 13, 2016

Key clinical point: Monthly, noninvasive measurement of lung fluid levels using lung impedance produced better fluid control in heart failure pati...

Video

Stem cells show heart failure benefits in phase II trial

Author:: Mitchel L. Zoler, PhD

Publish date: April 9, 2016

Severe, ischemic heart failure patients saw declines in death and cardiovascular hospitalizations after myocardial injection with autologous bone marr...

News

PCSK9 inhibitor overcomes muscle-related statin intolerance

Author:: Mitchel L. Zoler, PhD

Publish date: April 4, 2016

CHICAGO – Muscle-related statin intolerance was reproducible in many patients, but most could tolerate and respond robustly to a PCSK9 inhibitor.

News

TAVR matches surgery in intermediate-risk patients

Author:: Mitchel L. Zoler, PhD

Publish date: April 3, 2016

Transcatheter aortic-valve replacement performed as well as surgical-valve replacement in patients with an intermediate mortality risk in a prospectiv...

Video

VIDEO: PARTNER 2 results extend TAVR to intermediate-risk patients

Author:: Mitchel L. Zoler, PhD

Publish date: April 2, 2016

News

Prepsychosis links with elevated metabolic syndrome

Author:: Mitchel L. Zoler, PhD

Publish date: April 2, 2016

Key clinical point: People at high risk for a first psychosis episode had an increased prevalence of certain metabolic syndrome components, compar...

News

Breast cancer treatment linked to mild systolic dysfunction

Author:: Mitchel L. Zoler, PhD

Publish date: March 31, 2016

Breast cancer patients who underwent chemotherapy or radiotherapy had about a two-fold increased prevalence of mild systolic cardiac dysfunction a med...

News

Phone monitoring program helps cut chemotherapy symptom severity

Author:: Mitchel L. Zoler, PhD

Publish date: March 31, 2016

A telephone-based system to monitor chemotherapy-induced symptoms when patients are home and facilitate interventions as needed led to significant cut...

Video

VIDEO: Trastuzumab plus lapatinib erases selected breast cancers

Author:: Mitchel L. Zoler, PhD

Publish date: March 28, 2016

An unexpectedly dramatic benefit from combining trastuzumab and lapatinib when briefly treating women scheduled for breast cancer surgery has research...